Discovery of candidate biomarkers

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Properly performed, biomarker discovery can lead to effective candidates that can ultimately serve as predictors of disease, medical condition, define therapeutic parameters, and many other applications in medicine. Preferably, biomarkers comprise a panel of indicators, e.g. proteins and/or peptides that can be predictive or diagnostic of the medical condition of interest. Emphasis here is placed on “panel,” as single candidates are rarely sufficient to provide the necessary sensitivity and specificity. To develop an effective panel that survives the development process described in Chap. 19, proper experimental design and attention to important statistical parameters are critical to ensure success. Errors in discovery can lead to an inefficient use of expensive resources, as these may not be uncovered until the latter stages in biomarker development. Hence, accuracy, precision, and an estimate of the power of the proposed analyses are critical in the discovery of the panel of candidate biomarkers by proteomic methods, as is the selection of statistical approaches to refine and appropriately reduce the dataset for subsequent confirmatory assays.

Keywords

  • Antibody depletion
  • Biomarker discovery
  • Plasma
  • Protein pool
  • Serum

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Wiktorowicz, J. E., & Soman, K. V. (2016). Discovery of candidate biomarkers. In Advances in Experimental Medicine and Biology (Vol. 919, pp. 443-462). (Advances in Experimental Medicine and Biology; Vol. 919). Springer New York LLC. https://doi.org/10.1007/978-3-319-41448-5_21